• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Introduction to 2-phenoxypyridin-3-amine (CAS No. 28664-62-2)

2-phenoxypyridin-3-amine, identified by the Chemical Abstracts Service Number (CAS No.) 28664-62-2, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyridine family, characterized by a nitrogen-containing aromatic ring fused with a phenol-derived oxygen-containing group. The structural configuration of 2-phenoxypyridin-3-amine makes it a versatile scaffold for the development of novel bioactive molecules, particularly in the quest for targeted therapeutic agents.

The molecular structure of 2-phenoxypyridin-3-amine consists of a pyridine ring substituted at the 3-position with an amine group (-NH?) and at the 2-position with a phenoxy group (-O-C?H?). This arrangement imparts unique electronic and steric properties to the molecule, making it an attractive candidate for further derivatization and functionalization. The presence of both electron-donating amine and electron-withdrawing phenoxy groups allows for modulation of reactivity, solubility, and binding affinity, which are critical parameters in drug design.

In recent years, 2-phenoxypyridin-3-amine has been extensively studied for its potential applications in medicinal chemistry. One of the most compelling areas of research involves its role as a key intermediate in the synthesis of small-molecule inhibitors targeting various biological pathways. Notably, this compound has shown promise in the development of kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases. The pyridine moiety serves as a privileged scaffold, facilitating interactions with protein targets through hydrogen bonding and hydrophobic interactions.

Recent advancements in computational chemistry have enabled the rational design of derivatives of 2-phenoxypyridin-3-amine that exhibit enhanced potency and selectivity. Molecular docking studies have revealed that modifications at the 5-position of the pyridine ring or variations in the phenyl ring attached to the phenoxy group can significantly influence binding affinity to protein targets. These insights have guided the synthesis of novel analogs aimed at improving pharmacokinetic profiles and reducing off-target effects.

Moreover, 2-phenoxypyridin-3-amine has been explored as a precursor in the development of antimicrobial agents. The combination of a nitrogen-rich heterocycle and an oxygen-containing aromatic group creates a molecular environment conducive to disrupting bacterial cell membranes or inhibiting essential metabolic pathways. Preliminary studies have demonstrated that certain derivatives exhibit promising activity against multidrug-resistant strains, highlighting their potential as next-generation antibiotics.

The synthesis of 2-phenoxypyridin-3-amine typically involves multi-step organic reactions starting from readily available pyridine derivatives. Common synthetic routes include nucleophilic substitution reactions, where halogenated pyridines are reacted with phenol derivatives under controlled conditions to introduce the phenoxy group. Subsequent functionalization at the 3-position via reductive amination or direct amine introduction completes the molecular architecture. Advances in green chemistry have also led to more sustainable synthetic methodologies, reducing waste and improving yields.

In academic research, 2-phenoxypyridin-3-amine has been employed as a building block for exploring structure-activity relationships (SAR) in drug discovery. By systematically varying substituents on different parts of the molecule, researchers can dissect how specific structural features contribute to biological activity. This approach has been instrumental in identifying lead compounds for further optimization through combinatorial chemistry and high-throughput screening (HTS) techniques.

The pharmacological profile of 2-phenoxypyridin-3-amine is further enhanced by its ability to cross biological membranes due to its moderate lipophilicity. This property is crucial for achieving adequate bioavailability, ensuring that therapeutic doses reach their target sites effectively. Additionally, its stability under physiological conditions makes it suitable for formulation into various drug delivery systems, including oral tablets and injectable solutions.

Looking ahead, the future prospects for 2-phenoxypyridin-3-amine are promising, with ongoing research focusing on expanding its therapeutic applications. Investigating its potential as an antiviral agent or in neurodegenerative disease treatment is an emerging area of interest. Collaborative efforts between academia and industry are expected to accelerate the translation of laboratory findings into clinical candidates, bringing new treatments to patients suffering from unmet medical needs.

In conclusion, 2-phenoxypyridin-3-am ine (CAS No. 28664-62-2) represents a valuable compound in pharmaceutical research due to its versatile structural framework and potential bioactivity. Its role as an intermediate in drug development underscores its importance in modern medicinal chemistry. As synthetic methodologies continue to evolve and computational tools become more sophisticated, the applications of this compound are likely to expand, contributing significantly to advancements in human health.

• 25194-67-6(6-Phenoxypyridin-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)